In this review, three types of inhibitors in ESCC will be introduced, namely Akt inhibitors, PI3K inhibitors and mTOR inhibitors (Figure 2 and Supplementary Table S1). This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.